Wafik El-Deiry Md Facp

FAQ About Wafik El-Deiry Md Facp

• What is Wafik El-Deiry Md Facp's address?

  Wafik El-Deiry Md Facp is located at
  Philadelphia, Pennsylvania, United States

• What is Wafik El-Deiry Md Facp's job title?

  Wafik El-Deiry Md Facp is a
  Wafik El-Deiry, MD, PhD, FACP an American Cancer Society Research Professor, is Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University. He was previously Deputy Director & Program Leader at Fox Chase Cancer Center, Rose Dunlap Professor of Medicine & Chief of Hematology/Oncology, and Interim Director at Penn State Cancer Institute. Dr. El-Deiry joined University of Pennsylvania as Assistant Professor of Medicine & Genetics in 1994, was promoted to Associate Professor with tenure in 1999 & Professor of Medicine, Pharmacology & Genetics with tenure in 2005. He was an Investigator of the Howard Hughes Medical Institute from 1995-2004. He served as co-Leader of the Radiobiology & Imaging Program at the Abramson Cancer Center & Associate Director for Physician-Scientist Training in Hem/Onc at UPenn. He earned MD & PhD degrees at University of Miami & completed medicine residency & oncology fellowship at Johns Hopkins. Dr. El-Deiry discovered p21(WAF1) as p53 target gene, cell cycle inhibitor, & tumor suppressor that explained the mammalian cell stress response. This was the most highly cited original work published in Cell. He discovered TRAIL receptor DR5 as p53 target, & ONC201/TIC10 as TRAIL pathway, integrated stress response inducer & cancer therapeutic with efficacy in diffuse midline glioma & other tumors. Dr. El-Deiry has >500 publications & edited 6 books. He has served on editorial boards including as Associate Editor for the Journal of Clinical Investigation from 2007-2010 and Editor-in-Chief of Cancer Biology & Therapy from 2001 to 2019. He is active as an NCI grant reviewer, has served on ACS Council, lectures widely & is a highly cited researcher (H-index 128 in 2024 with > 103,000 citations in Google Scholar). He was named one of America's Top Oncologists by Consumer Res Council of America in 2008 & 2009. He is a member of Faculty of 1000 (Faculty Opinions), Interurban Clinical Club (President, 2013-2014), American Society of Clinical Investigation (ASCI) & Association of American Physicians (AAP). He organized international meetings & won 2009 Kuwait International Prize in Applied Sciences. He founded Oncoceutics in 2004 (acquired by Chimerix in 2021), p53-Therapeutics, and SMURF-Therapeutics. He became a member of the Johns Hopkins University Society of Scholars in 2014. He received the inventor of the year award from Brown University in 2022 and 2023. He is a practicing physician-scientist specializing in colorectal cancer treatment & precision oncology. Oncotarget

• What industry does Wafik El-Deiry Md Facp currently work in?

  Wafik El-Deiry Md Facp currently works in the
  Oncotarget

• What is Wafik El-Deiry Md Facp's area of expertise?

  Wafik El-Deiry Md Facp specializes in
  Wafik El-Deiry, MD, PhD, FACP an American Cancer Society Research Professor, is Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University. He was previously Deputy Director & Program Leader at Fox Chase Cancer Center, Rose Dunlap Professor of Medicine & Chief of Hematology/Oncology, and Interim Director at Penn State Cancer Institute. Dr. El-Deiry joined University of Pennsylvania as Assistant Professor of Medicine & Genetics in 1994, was promoted to Associate Professor with tenure in 1999 & Professor of Medicine, Pharmacology & Genetics with tenure in 2005. He was an Investigator of the Howard Hughes Medical Institute from 1995-2004. He served as co-Leader of the Radiobiology & Imaging Program at the Abramson Cancer Center & Associate Director for Physician-Scientist Training in Hem/Onc at UPenn. He earned MD & PhD degrees at University of Miami & completed medicine residency & oncology fellowship at Johns Hopkins. Dr. El-Deiry discovered p21(WAF1) as p53 target gene, cell cycle inhibitor, & tumor suppressor that explained the mammalian cell stress response. This was the most highly cited original work published in Cell. He discovered TRAIL receptor DR5 as p53 target, & ONC201/TIC10 as TRAIL pathway, integrated stress response inducer & cancer therapeutic with efficacy in diffuse midline glioma & other tumors. Dr. El-Deiry has >500 publications & edited 6 books. He has served on editorial boards including as Associate Editor for the Journal of Clinical Investigation from 2007-2010 and Editor-in-Chief of Cancer Biology & Therapy from 2001 to 2019. He is active as an NCI grant reviewer, has served on ACS Council, lectures widely & is a highly cited researcher (H-index 128 in 2024 with > 103,000 citations in Google Scholar). He was named one of America's Top Oncologists by Consumer Res Council of America in 2008 & 2009. He is a member of Faculty of 1000 (Faculty Opinions), Interurban Clinical Club (President, 2013-2014), American Society of Clinical Investigation (ASCI) & Association of American Physicians (AAP). He organized international meetings & won 2009 Kuwait International Prize in Applied Sciences. He founded Oncoceutics in 2004 (acquired by Chimerix in 2021), p53-Therapeutics, and SMURF-Therapeutics. He became a member of the Johns Hopkins University Society of Scholars in 2014. He received the inventor of the year award from Brown University in 2022 and 2023. He is a practicing physician-scientist specializing in colorectal cancer treatment & precision oncology.

• Which languages does Wafik El-Deiry Md Facp speak? 

  Wafik El-Deiry Md Facp speaks the following languages:
  No languages available.

• Which industries has Wafik El-Deiry Md Facp previously worked in?   

  Wafik El-Deiry Md Facp has prior experience in the following industries:
  Brown University , Fox Chase Cancer Center , Fox Chase Cancer Center , Fox Chase Cancer Center , Fox Chase Cancer Center , Penn State University , Penn State College Of Medicine , Penn State College Of Medicine , University Of Pennsylvania , Penn State Hershey Cancer Institute , Penn State Hershey Medical Center , Cancer Biology And Therapy

• What is Wafik El-Deiry Md Facp’s work experience?  

  Wafik El-Deiry Md Facp has the following professional experience:
  Oncotarget , National Academy Of Inventors , Win Consortium In Cancer Personalized Medicine , Brown University , Smurf Therapeutics , Brown University , Waf1 Crew , Brown University , Lifespan , The Warren Alpert Medical School Of Brown University , Brown University , Lifespan , Brown University , Brown University , Fox Chase Cancer Center , The Warren Alpert Medical School Of Brown University , Fox Chase Cancer Center , Penn State College Of Medicine , Fox Chase Cancer Center , Fox Chase Cancer Center , Fox Chase Cancer Center , P53 Therapeutics , Penn State University , Penn State College Of Medicine , Penn State College Of Medicine , Oncotarget , University Of Pennsylvania , Penn State Hershey Cancer Institute , Penn State Hershey Medical Center , American Cancer Society , Interurban Clinical Club , Oncoceutics , Cancer Biology And Therapy .

• How can I find Wafik El-Deiry Md Facp on LinkedIn?  

  You can view Wafik El-Deiry Md Facp’s
  LinkedIn profile at LinkedIn URL.

• What are Wafik El-Deiry Md Facp’s work email addresses?  

  Wafik El-Deiry Md Facp’s work email addresses are
  [email protected] .

• What company does Wafik El-Deiry Md Facp work for?  

  Wafik El-Deiry Md Facp works at
  Oncotarget